Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy
about
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Tolerance and efficacy of BRAF ...... death protein 1-based therapy
@en
type
label
Tolerance and efficacy of BRAF ...... death protein 1-based therapy
@en
prefLabel
Tolerance and efficacy of BRAF ...... death protein 1-based therapy
@en
P2093
P356
P1433
P1476
Tolerance and efficacy of BRAF ...... death protein 1-based therapy
@en
P2093
Alexander M Menzies
Angelica Bialczak
Cathy Y Xia
Daniel Y Wang
Jeewon Chon
Karim R Saab
Kelly T Abbate
Meghan J Mooradian
Ryan J Sullivan
P304
P356
10.1002/CNCR.31889
P577
2018-12-06T00:00:00Z